Comparison of Resin Salve and Conventional Octenidine in Patients With Neuropathic Diabetic Foot Ulcers - a Prospective, Randomized and Controlled Clinical Trial
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 35
- 试验地点
- 2
- 主要终点
- Wound healing
研究概览
简要总结
Prevalence of diabetic foot ulcers are reported to be 15% in patients who suffer from diabetes and ulcerations are present in 84% of all diabetes-related amputations. Peripheral neuropathy leading to unperceived trauma seems to be the major cause of diabetic foot ulcers with 45-60% of ulcers to be considered merely neuropathic and 45% of mixed, neuropathic and ischemic etiology. Ulceration of lower limb is one of the most common complications related with diabetes and one of the major causes for hospitalization of diabetic patients. The most significant contributors to diabetic lower limb ulceration are neuropathy, deformity, uncontrolled elevated plantar pressure, poor glycemic status, peripheral vascular disease, male gender and duration of diabetes. Treatment of lower limb ulcers imposes an enormous burden on health care resources worldwide, and at least 33% of all expenses are spent to treat diabetic ulcers manifested as a complication of diabetes.
Although at least 170 topical wound care products are available, evidence of the superiority of one over another is tenuous, well-designed randomized, controlled trials are rare, and the number of case-control or observational studies is limited. In recent years, salve prepared from Norway spruce (Picea abies) resin has successfully been used in medical context to treat both acute and chronic wounds and ulcers of various origins. The objective of this prospective, randomized and controlled clinical trial is to investigate healing rate and healing time of neuropathic diabetic foot ulcer in patients, who are suffering from infected fore- or mid-foot ulceration (PEDIS-classification ≥ Grade II; 19) originated from Type I or II diabetes, and in patients whose diabetic ulcerations are candidates for topical treatment with resin (Study treatment) or octenidine (Control treatment). In addition, factors contributing with delayed healing of ulceration, antimicrobial properties, safety and cost-effectiveness of the resin salve treatment and control treatment will be analyzed.
详细描述
PRIMARY OBJECTIVES
Primary objectives are:
- to scrutinize complete healing of neuropathic diabetic foot ulceration over time.
- to analyze successful eradication rate of pathogenic bacteria from the ulcers within the study period as documented by negative swab culture.
- to analyze the rate of ulcers with 50% decrease in ulcer size and disappearing of clinical signs of infection over time.
SECONDARY OBJECTIVES
Secondary objectives are:
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 80 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •an adult patient (18-80 years) suffering from infected neuropathic fore- or mid-foot ulceration originated from type I or II diabetes (PEDIS-classification ≥ Grade II).
排除标准
- •a patient whose life expectancy is less than 6 months
- •an ulceration of ischemic or neuroischemic origin
- •presence of systemic inflammatory response signs
- •heel ulceration
- •presence of osteomyelitis
- •pregnancy
- •known hypersensitivity to any of the ingredient including in the study or control treatment products
- •a patient who is unable to give informed consent
- •a patient who has an advanced malignant disease.
结局指标
主要结局
Wound healing
时间窗: Within 6 months
To scrutinize complete healing of neuropathic diabetic foot ulceration over time.
次要结局
- Eradication of bacteria(Within six months)
研究者
Janne J. Jokinen
MD, PhD
Helsinki University Central Hospital
